MIMEDX Group, Inc.

MIMEDX Group, Inc. Patients are why we are here. MIMEDX has supplied over two million allografts, through both direct and consignment shipments.

MIMEDX is an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, developing and distributing placental tissue allografts with patent-protected, proprietary processes for multiple sectors of healthcare. As a pioneer in placental biologics, we have both a core business, focused on addressing the needs of patients with acute and chronic non-healing wounds, and a prom

ising late-stage pipeline targeted at decreasing pain and improving function for patients with degenerative musculoskeletal conditions. We derive our products from human placental tissues and process these tissues using our proprietary methods, including the PURION® process. We employ Current Good Tissue Practices, Current Good Manufacturing Practices, and terminal sterilization to produce our allografts. For additional information, please visit www.mimedx.com.

08/27/2026

"A tremendous time saver." That's how Jeff Kingery, Chief Clinical Officer at WoundGenex, describes ordering with MIMEDX Connect.

"It is a tremendous time saver to work in Connect because there is no longer the need to dial up somebody and have a conversation. You simply log in, enter your data, and press submit, and the information flows."

Explore MIMEDX Connect: https://mimedx.info/connect

In surgery, every minute matters.AMNIOFIX® Thyroid Shields combine preconfigured sizing and easy application to help str...
08/26/2026

In surgery, every minute matters.

AMNIOFIX® Thyroid Shields combine preconfigured sizing and easy application to help streamline thyroid procedures while delivering advanced protection on exposed tissues.

Precision. Efficiency. Science. Learn more: https://mimedx.info/Thyroid-Surgery

Many wounds that are failing to close are stuck in inflammation, and that’s where RegenKit®-Wound Gel autologous PRP the...
08/25/2026

Many wounds that are failing to close are stuck in inflammation, and that’s where RegenKit®-Wound Gel autologous PRP therapy comes in.

Chronic wounds often stall in a prolonged inflammatory state, where dysregulated leukocyte activity and elevated protease levels have been associated with delayed progression toward healing. In that environment, the composition of the PRP you introduce matters.

Explore a new Product in Practice module on Wound Care Today USA to learn how RegenKit®-Wound Gel is prepared at the bedside from a small blood draw, the science behind its use, and the evidence supporting its role in wound management.

Interact with the module now: https://mimedx.info/PRP-Product-In-Practice

WCT USA

RegenKit®–Wound Gel, our autologous PRP wound gel prepared at the point of care, is now available through the MIMEDX par...
08/20/2026

RegenKit®–Wound Gel, our autologous PRP wound gel prepared at the point of care, is now available through the MIMEDX partnership with WoundGenex. This program, offered by WoundGenex, supports timely patient access to advanced wound care technology by removing financial barriers.

🔗 Learn more and reach out to a WoundGenex rep: https://mimedx.info/WoundGenex-Partner-Site

08/18/2026

Your reimbursement workflow, simplified. MIMEDX Connect helps you track IVRs, stay ahead of reimbursement news, and access audit support and analytics, all in one place.

Explore MIMEDX Connect: https://mimedx.info/connect

Not every wound is straightforward. G4Derm® Plus is designed for the ones that aren't.Flowable. Acellular. Precise. This...
08/17/2026

Not every wound is straightforward. G4Derm® Plus is designed for the ones that aren't.

Flowable. Acellular. Precise. This biomimetic extracellular matrix (ECM) supports healing, guards the wound bed with an antibacterial barrier,* and reaches where treatment is needed — even in deeper voids and undermining areas.

Learn more: https://mimedx.info/G4Derm-Plus

*Data on File, FDA 510(k) submission package. Antibacterial Barrier Effectiveness of G4Derm Plus. Gel4Med, Inc.

Distributed by MIMEDX. Owned and manufactured by Gel4Med Inc.

From MIMEDX's number 1 ranked surgical amniotic portfolio comes targeted thyroid surgery exposed tissue protection.¹AMNI...
08/11/2026

From MIMEDX's number 1 ranked surgical amniotic portfolio comes targeted thyroid surgery exposed tissue protection.¹

AMNIOFIX® Thyroid Shields cover and protect the recurrent laryngeal nerve and parathyroid glands, thereby supporting the healing process after thyroidectomy procedures.

Built for precision. Designed for thyroid surgery. Learn more: https://mimedx.info/Thyroid-Surgery

1. BioMedGPS — SmartTRAK. Q1 2025 US Surgical Amniotic Tissue Market SoC Report – Revenues/Shares. https://www.smarttrak.com. Accessed Aug 13, 2025.

Join us tomorrow for Healing Complex Wounds with Autologous PRP.MIMEDX is sponsoring this live webinar with Wound Care T...
08/10/2026

Join us tomorrow for Healing Complex Wounds with Autologous PRP.

MIMEDX is sponsoring this live webinar with Wound Care Today USA, featuring Peter Moyer, DPM, FACFAS, and Dorothy Kurtz Phelan, DPM, CWSP, D-FBAS, FACFAS.

The session will cover clinical evidence, case-based outcomes, and practical guidance on autologous PRP wound gel for complex wound care.

Tuesday, August 11
12 PM ET | 11 AM CT | 9 AM PT

Register today: https://mimedx.info/RegenKit-Wound-Gel-WCT-USA-Webinar

G4Derm® Plus is an acellular flowable extracellular matrix designed to manage complex wounds.It supports healing and ser...
08/03/2026

G4Derm® Plus is an acellular flowable extracellular matrix designed to manage complex wounds.

It supports healing and serves as an antibacterial barrier to protect the wound bed from external contamination.*

The versatile product is intended to facilitate controlled handling and application in variable wound surfaces and provides an Applicator Tip to precisely reach deeper voids and undermining areas.

Learn more about the versatility of G4Derm Plus for your practice: https://mimedx.info/G4Derm-Plus

G4Derm Plus is owned and manufactured by Gel4Med Inc.

When complex wounds stall, clinicians may need to reassess the next step in care.Join MIMEDX and Wound Care Today USA fo...
07/30/2026

When complex wounds stall, clinicians may need to reassess the next step in care.

Join MIMEDX and Wound Care Today USA for Healing Complex Wounds with Autologous PRP, a live webinar focused on clinical evidence and case-based outcomes with RegenKit®-Wound Gel.

This session will explore difficult-to-treat wounds, including diabetic foot ulcers and post-surgical wounds, through a practical, case-based discussion.

Tuesday, August 11
12 PM ET | 11 AM CT | 9 AM PT

Register today: https://mimedx.info/RegenKit-Wound-Gel-WCT-USA-Webinar

Address

Atlanta, GA

Telephone

+17706519100

Website

Alerts

Be the first to know and let us send you an email when MIMEDX Group, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category